Skip to main content

Gabriel Victora named 2017 MacArthur Fellow

One of the most prestigious funding programs in the world, the MacArthur fellows program awards grants to exceptionally creative individuals as an investment in their potential.

New smell test could aid early detection of Alzheimer’s and Parkinson’s

Problems with olfaction have been linked to a variety of health conditions. Scientists have developed new tests to detect smell loss more reliably.

Stress has dramatically different effects on male and female mouse brains

Scientists have found unexpected differences in how male and female mice respond to stress. Their findings are raising big questions about sex discrepancies in the brain and their impact on neuropsychiatric disease.

Titia de Lange to receive 2017 Rosenstiel Award

de Lange is honored for her elucidation of the mechanism of telomere protection and the maintenance of genome stability.

JoAnne Stubbe of MIT will receive the 2017 Pearl Meister Greengard Prize

Stubbe is being recognized for illuminating the processes that drive DNA replication and repair. Her research has led to the development of several cancer therapies.

Rockefeller University biologist Michael W. Young honored with Nobel Prize for pioneering studies on circadian rhythm

Rockefeller University biologist Michael W. Young, who studies the biological clocks that regulate sleep, metabolism, and response to disease, is this year’s recipient of the Nobel Prize in Physiology or Medicine.

Simple strategy could lead to a “universal” flu vaccine

To keep up with evasive flu viruses, new vaccines must be developed each year. Scientists are devising a strategy to better prevent the disease without annual shots.

Infectious diseases pioneer and Rockefeller Professor Emeritus John Zabriskie dies at 88

Zabriskie was a leader in the investigation of streptococcal infections and their long-term side effects, including rheumatic fever and autoimmune disorders. He died August 17 at the age of 88.

>

In brief: Alternative CRISPR system is less specific, more robust

Scientists found that a system called CRISPR-Cas10 can target rapidly mutating viruses.

Gut bacteria that “talk” to human cells may lead to new treatments

Scientists developed a method to genetically engineer gut bacteria to produce molecules that have the potential to treat certain disorders by altering human metabolism.